DPM3 and neuromuscular disease caused by qualitative or quantitative defects of alpha-dystroglycan: Loss of function due to DPM3 gene mutations clinically results in a rare type of limb–girdle muscular dystrophy–dystroglycanopathy, presenting with progressive proximal muscle weakness and DCM.